Generalized Anxiety Disorder. Anxiety that is generalized and persistent but not restricted to, or even strongly predominating in, any particular environmental circumstances (i.e. it is
Conditions
Interventions
Intervention 1: Self hypnosis Training: for experimental groups and for 6 weeks. Intervention 2: Citalopram: In this research in the form of tablets of 20 mg was prescribed once a day for 6 weeks for
Behavior
Treatment - Drugs
Self hypnosis Training: for experimental groups and for 6 weeks.
Citalopram: In this research in the form of tablets of 20 mg was prescribed once a day for 6 weeks for both of experimental and control groups.
Without self-hypnosis training sessions: for the Control group as a shame of interview for 6 weeks
Sponsors
Vice chancellor for research, Semnan University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion criteria: Diagnosis of Generalized Anxiety Disorder (GAD) by psychiatrist; Without comorbid disorders; To have not severe physical illness Exclusion criteria: Under treatment or other educational program ; The absence of more than two sessions
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Generalized Anxiety Disorder. Timepoint: Baseline-After intervention-Two months after intervention. Method of measurement: Spielberger's State-Trait Anxiety Inventory.;Quality of Life. Timepoint: Baseline- After the intervention-Two months after the intervention. Method of measurement: The World Health Organization Quality of Life Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactZahra Moghanizadeh
Mashhad University of Medical Sciences
Outcome results
None listed